http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020264412-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31716c1bdee8dc035af814d22534169c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168
filingDate 2020-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b39ff9dade40d6372a833bdcbab495b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e244842199ede6de6fd36b0329754ba8
publicationDate 2020-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020264412-A1
titleOfInvention Compositions for creatine supplementation in creatine non-responders
abstract Disclosed herein are methods for creatine supplementation for human subjects, particularly creatine non-responders.
priorityDate 2019-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016303061-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002001611-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226436620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400026

Total number of triples: 25.